“…CaMK-II diversity in all species is achieved through alternative promoter and/or exon usage (Griffith and Greenspan, 1993;Mayer et al, 1993Mayer et al, , 1994Mayer et al, , 1995Schworer et al, 1993;Edman and Schulman, 1994;Ramirez et al, 1997;Tombes and Krystal, 1997;Bayer et al, 1998Bayer et al, , 1999Hoch et al, 1998Hoch et al, , 2000Takeuchi and Fujisawa, 1998;Donai et al, 2000b;Mima et al, 2001;Hudmon and Schulman, 2002a). As many as seven alternative variable domain exons are used in different combinations to yield over three dozen unique isozymes (Tombes and Krystal, 1997;Bayer et al, 1998;Takeuchi et al, 2000a).…”